Zimbabwe has rejected a substantial US health deal worth $367m (272 million pounds) over five years because of Washington's request for confidential biological samples.
This move came to light following a government memo dated December was disclosed, revealing that President Emmerson Mnangagwa deemed the deal was "unbalanced".
An official spokesperson has since clarified that the US was requesting genetic material for research and commercial gain but was unwilling to share the benefits from any future vaccines.
"We will now turn to the difficult and regrettable process of scaling back our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had provided more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for more dialogue to reach a agreement acceptable to both sides so the nation's critical HIV treatment initiative can proceed.
Wider Implications
This development follows a comparable situation in Kenya, where a court suspended a related deal with the US following legal challenges were raised about the security of citizens' medical information.
After resuming office recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
USAID had managed assistance for the US government, but Trump argued its spending was "wasteful" and his government was seeking government-to-government deals to enhance openness and accountability.
Based on reports, Sixteen nations in Africa have so far agreed to these new agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Declined Deal
The money for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership would have delivered immense advantages for the people of Zimbabwe, especially the 1.2 million presently receiving HIV treatment via American-funded programmes," Tremont said.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"Our nation was requested to provide its genetic material and health information for a long time, without any equivalent assurance of benefiting from any scientific breakthroughs – like new medicines or tests – that might result from that provided information," he stated.
"Put simply, our country would supply the basic resources for scientific discovery without any certainty that the final treatments would be available to our population should a new health crisis arise."
National Interest and International Frameworks
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting frameworks previously established via the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing system created to deal with potential global health emergencies.
"This system is intended to ensure that when a country contributes its information, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to create them."
The government's concerns over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We welcome further discussions with our American counterparts on how future collaboration could be structured in a manner that honours the sovereignty and interests of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the official position, but recommended that talks need to persist given that a large portion of the country's Aids initiatives depended on foreign aid.
"In cases where specific concerns arise, such as those relating to data governance or agreement terms, these can frequently be resolved through technical clarification and mutually agreed protections," the group said.
The situation highlights the complex tensions between receiving crucial foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.